{"transactions":[{"id":863922,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-03-04T21:36:54.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Board of Directors on January 26, 2026, with a grant date of March 2, 2026, and represents the Reporting Person's annual equity award for 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests in full on March 2, 2027, subject to the Reporting Person's continued service on the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":5.35,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001393007-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000139300726000002/ownership.xml","form_type":"4"}},{"id":1187395,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-01T21:03:07.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":23475,"price":2.1299,"value":49999.4025,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":183460,"source":{"system":"sec-edgar","filing":"0000950170-25-048691","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025048691/ownership.xml","form_type":"4"}},{"id":1224985,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-03-05T21:18:26.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Board of Directors on February 12, 2025, with a grant date of March 3, 2025, and represents the Reporting Person's annual equity award for 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests in full on March 3, 2026, subject to the Reporting Person's continued service on the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":2.46,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-25-033614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025033614/ownership.xml","form_type":"4"}},{"id":1471498,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-24T20:13:02.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall fully vest on the first anniversary after the Grant Date (06/20/2024), subject to a continued service relationship."}],"balance_after":23000,"derivative":{"exercise_price":10.65,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000950170-24-076724","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024076724/ownership.xml","form_type":"4"}},{"id":1476635,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T11:45:41.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":83,"price":10.8,"value":896.4,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":159985,"source":{"system":"sec-edgar","filing":"0000950170-24-074592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024074592/ownership.xml","form_type":"4"}},{"id":1476634,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T11:45:41.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":4504,"price":10.9,"value":49093.6,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":159902,"source":{"system":"sec-edgar","filing":"0000950170-24-074592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024074592/ownership.xml","form_type":"4"}},{"id":1494156,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T20:02:03.000Z","date":"2024-06-03","kind":"purchase","planned":false,"acquired":true,"shares":34246,"price":1.4598,"value":49992.3108,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":1553984,"source":{"system":"sec-edgar","filing":"0000950170-24-068638","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024068638/ownership.xml","form_type":"4"}},{"id":1708400,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-18T21:16:52.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":152962,"price":0.2699,"value":41284.4438,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":1519738,"source":{"system":"sec-edgar","filing":"0001437749-23-034752","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034752/rdgdoc.xml","form_type":"4"}},{"id":1708399,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-18T21:16:52.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":32238,"price":0.27,"value":8704.26,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":1366776,"source":{"system":"sec-edgar","filing":"0001437749-23-034752","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034752/rdgdoc.xml","form_type":"4"}},{"id":1711782,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-12-14T23:28:12.000Z","date":"2023-12-12","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vests 12/12/2024."}],"balance_after":2412500,"derivative":{"exercise_price":0.24,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001437749-23-034468","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034468/rdgdoc.xml","form_type":"4"}},{"id":1917677,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-04-19T21:52:20.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":false,"shares":23566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020, 25% vested on 6/23/2021, 25% vested on 6/23/2022 and the remaining 25% vested on 2/3/2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020, 25% vested on 6/23/2021, 25% vested on 6/23/2022 and the remaining 25% vested on 2/3/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020, 25% vested on 6/23/2021, 25% vested on 6/23/2022 and the remaining 25% vested on 2/3/2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020, 25% vested on 6/23/2021, 25% vested on 6/23/2022 and the remaining 25% vested on 2/3/2023."}],"balance_after":0,"derivative":{"exercise_price":0.61,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001437749-23-010666","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923010666/rdgdoc.xml","form_type":"4"}},{"id":1917676,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-04-19T21:52:20.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":163934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020, 25% vested on 6/23/2021, 25% vested on 6/23/2022 and the remaining 25% vested on 2/3/2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020, 25% vested on 6/23/2021, 25% vested on 6/23/2022 and the remaining 25% vested on 2/3/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020, 25% vested on 6/23/2021, 25% vested on 6/23/2022 and the remaining 25% vested on 2/3/2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020, 25% vested on 6/23/2021, 25% vested on 6/23/2022 and the remaining 25% vested on 2/3/2023."}],"balance_after":0,"derivative":{"exercise_price":0.61,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":23566},"source":{"system":"sec-edgar","filing":"0001437749-23-010666","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923010666/rdgdoc.xml","form_type":"4"}},{"id":1917675,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-19T21:52:20.000Z","date":"2023-04-17","kind":"exercise","planned":false,"acquired":true,"shares":23566,"price":0.61,"value":14375.26,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":1334538,"source":{"system":"sec-edgar","filing":"0001437749-23-010666","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923010666/rdgdoc.xml","form_type":"4"}},{"id":1917674,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-19T21:52:20.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":163934,"price":0.61,"value":99999.74,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":1310972,"source":{"system":"sec-edgar","filing":"0001437749-23-010666","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923010666/rdgdoc.xml","form_type":"4"}},{"id":1997782,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-02-24T00:33:37.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% vests 2/21/2024."}],"balance_after":2370000,"derivative":{"exercise_price":0.38,"expiration_date":"2033-02-21","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001437749-23-004434","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923004434/rdgdoc.xml","form_type":"4"}},{"id":1997781,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-02-24T00:33:37.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":470000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vest monthly over three years."}],"balance_after":2140000,"derivative":{"exercise_price":0.38,"expiration_date":"2033-02-21","underlying":"Common Stock","underlying_shares":470000},"source":{"system":"sec-edgar","filing":"0001437749-23-004434","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923004434/rdgdoc.xml","form_type":"4"}},{"id":2113867,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-11-17T23:43:12.000Z","date":"2022-11-15","kind":"purchase","acquired":true,"shares":100000,"price":0.3354,"value":33540.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":1147038,"source":{"system":"sec-edgar","filing":"0001437749-22-027681","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774922027681/rdgdoc.xml","form_type":"4"}},{"id":2201132,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2022-07-28T21:21:15.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":940000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 7/21/2022, and the remaining 75% will vest over the next three (3) years, commencing on 7/21/2023, until fully vested."}],"balance_after":1670000,"derivative":{"exercise_price":0.33,"expiration_date":"2032-07-21","underlying":"Common Stock","underlying_shares":940000},"source":{"system":"sec-edgar","filing":"0001437749-22-018032","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774922018032/rdgdoc.xml","form_type":"4"}},{"id":2238467,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-06-09T21:20:40.000Z","date":"2022-06-07","kind":"purchase","acquired":true,"shares":75000,"price":0.2964,"value":22230.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":1047038,"source":{"system":"sec-edgar","filing":"0001437749-22-014698","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774922014698/rdgdoc.xml","form_type":"4"}},{"id":2496955,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2021-11-25T01:00:57.000Z","date":"2021-11-23","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% will vest on 6/18/2022. The shares exercised on 11/23/2021 represent the shares that vested on 6/18/2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% will vest on 6/18/2022. The shares exercised on 11/23/2021 represent the shares that vested on 6/18/2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% will vest on 6/18/2022. The shares exercised on 11/23/2021 represent the shares that vested on 6/18/2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% will vest on 6/18/2022. The shares exercised on 11/23/2021 represent the shares that vested on 6/18/2021."}],"balance_after":62500,"derivative":{"exercise_price":0.43,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001437749-21-027408","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921027408/rdgdoc.xml","form_type":"4"}},{"id":2496954,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2021-11-25T01:00:57.000Z","date":"2021-11-23","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, 25% vested on 6/13/2020 and the remaining 25% vested on 6/13/2021. The shares exercised on 11/23/2021 represent the shares that vested on 6/13/2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, 25% vested on 6/13/2020 and the remaining 25% vested on 6/13/2021. The shares exercised on 11/23/2021 represent the shares that vested on 6/13/2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, 25% vested on 6/13/2020 and the remaining 25% vested on 6/13/2021. The shares exercised on 11/23/2021 represent the shares that vested on 6/13/2021."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, 25% vested on 6/13/2020 and the remaining 25% vested on 6/13/2021. The shares exercised on 11/23/2021 represent the shares that vested on 6/13/2021."}],"balance_after":0,"derivative":{"exercise_price":0.46,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001437749-21-027408","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921027408/rdgdoc.xml","form_type":"4"}},{"id":2496953,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-11-25T01:00:57.000Z","date":"2021-11-23","kind":"exercise","acquired":true,"shares":62500,"price":0.43,"value":26875.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":972038,"source":{"system":"sec-edgar","filing":"0001437749-21-027408","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921027408/rdgdoc.xml","form_type":"4"}},{"id":2496952,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-11-25T01:00:57.000Z","date":"2021-11-23","kind":"exercise","acquired":true,"shares":62500,"price":0.46,"value":28750.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":909538,"source":{"system":"sec-edgar","filing":"0001437749-21-027408","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921027408/rdgdoc.xml","form_type":"4"}},{"id":2642958,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2021-07-06T20:23:48.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":480000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 7/1/2021, and the remaining 75% will vest over the next three (3) years, commencing on 7/1/2022, until fully vested."}],"balance_after":855000,"derivative":{"exercise_price":0.79,"expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":480000},"source":{"system":"sec-edgar","filing":"0001437749-21-016445","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921016445/rdgdoc.xml","form_type":"4"}},{"id":2788097,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Warrant (right to buy)","published_at":"2021-03-16T20:19:40.000Z","date":"2021-03-12","kind":"other","acquired":false,"shares":24038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025. This transaction represents an exercise for all of the warrants purchased as part of the public offering that closed on October 22, 2020."},{"field":"shares","element":"transactionShares","label":"F5","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025. This transaction represents an exercise for all of the warrants purchased as part of the public offering that closed on October 22, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025. This transaction represents an exercise for all of the warrants purchased as part of the public offering that closed on October 22, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025. This transaction represents an exercise for all of the warrants purchased as part of the public offering that closed on October 22, 2020."}],"balance_after":0,"derivative":{"exercise_price":0.57,"exercise_date":"2020-10-22","expiration_date":"2025-10-22","underlying":"Common Stock","underlying_shares":24038},"source":{"system":"sec-edgar","filing":"0001437749-21-006164","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921006164/rdgdoc.xml","form_type":"4"}},{"id":2788096,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2021-03-16T20:19:40.000Z","date":"2021-03-12","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020 and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested. The shares exercised on 3/12/2021 represent the shares that vested on 6/23/2020."},{"field":"shares","element":"transactionShares","label":"F4","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020 and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested. The shares exercised on 3/12/2021 represent the shares that vested on 6/23/2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020 and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested. The shares exercised on 3/12/2021 represent the shares that vested on 6/23/2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020 and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested. The shares exercised on 3/12/2021 represent the shares that vested on 6/23/2020."}],"balance_after":187500,"derivative":{"exercise_price":0.61,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001437749-21-006164","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921006164/rdgdoc.xml","form_type":"4"}},{"id":2788095,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2021-03-16T20:19:40.000Z","date":"2021-03-12","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020 and the remaining 50% will vest over the next two (2) years, commencing on 6/18/2021, until fully vested. The shares exercised on 3/12/2021 represent the shares that vested on 6/18/2020."},{"field":"shares","element":"transactionShares","label":"F3","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020 and the remaining 50% will vest over the next two (2) years, commencing on 6/18/2021, until fully vested. The shares exercised on 3/12/2021 represent the shares that vested on 6/18/2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020 and the remaining 50% will vest over the next two (2) years, commencing on 6/18/2021, until fully vested. The shares exercised on 3/12/2021 represent the shares that vested on 6/18/2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020 and the remaining 50% will vest over the next two (2) years, commencing on 6/18/2021, until fully vested. The shares exercised on 3/12/2021 represent the shares that vested on 6/18/2020."}],"balance_after":125000,"derivative":{"exercise_price":0.43,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001437749-21-006164","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921006164/rdgdoc.xml","form_type":"4"}},{"id":2788094,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2021-03-16T20:19:40.000Z","date":"2021-03-12","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, 25% vested on 6/13/2020 and the remaining 25% will vest on 6/13/2021. The shares exercised on 3/12/2021 represent the shares that vested on 6/13/2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, 25% vested on 6/13/2020 and the remaining 25% will vest on 6/13/2021. The shares exercised on 3/12/2021 represent the shares that vested on 6/13/2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, 25% vested on 6/13/2020 and the remaining 25% will vest on 6/13/2021. The shares exercised on 3/12/2021 represent the shares that vested on 6/13/2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, 25% vested on 6/13/2020 and the remaining 25% will vest on 6/13/2021. The shares exercised on 3/12/2021 represent the shares that vested on 6/13/2020."}],"balance_after":62500,"derivative":{"exercise_price":0.46,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001437749-21-006164","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921006164/rdgdoc.xml","form_type":"4"}},{"id":2788093,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2021-03-16T20:19:40.000Z","date":"2021-03-12","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"100,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, 25% vested on 6/27/2018, 25% vested on 6/27/2019 and the remaining 25% vested on 6/27/2020. The shares exercised on 3/12/2021 represent the shares that vested on 6/27/2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"100,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, 25% vested on 6/27/2018, 25% vested on 6/27/2019 and the remaining 25% vested on 6/27/2020. The shares exercised on 3/12/2021 represent the shares that vested on 6/27/2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, 25% vested on 6/27/2018, 25% vested on 6/27/2019 and the remaining 25% vested on 6/27/2020. The shares exercised on 3/12/2021 represent the shares that vested on 6/27/2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"100,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, 25% vested on 6/27/2018, 25% vested on 6/27/2019 and the remaining 25% vested on 6/27/2020. The shares exercised on 3/12/2021 represent the shares that vested on 6/27/2020."}],"balance_after":0,"derivative":{"exercise_price":0.605,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-006164","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921006164/rdgdoc.xml","form_type":"4"}},{"id":2788092,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-03-16T20:19:40.000Z","date":"2021-03-12","kind":"other","acquired":true,"shares":24038,"price":0.57,"value":13701.66,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":847038,"source":{"system":"sec-edgar","filing":"0001437749-21-006164","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921006164/rdgdoc.xml","form_type":"4"}},{"id":2788091,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-03-16T20:19:40.000Z","date":"2021-03-12","kind":"exercise","acquired":true,"shares":62500,"price":0.61,"value":38125.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":823000,"source":{"system":"sec-edgar","filing":"0001437749-21-006164","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921006164/rdgdoc.xml","form_type":"4"}},{"id":2788090,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-03-16T20:19:40.000Z","date":"2021-03-12","kind":"exercise","acquired":true,"shares":62500,"price":0.43,"value":26875.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":760500,"source":{"system":"sec-edgar","filing":"0001437749-21-006164","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921006164/rdgdoc.xml","form_type":"4"}},{"id":2788089,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-03-16T20:19:40.000Z","date":"2021-03-12","kind":"exercise","acquired":true,"shares":62500,"price":0.46,"value":28750.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":698000,"source":{"system":"sec-edgar","filing":"0001437749-21-006164","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921006164/rdgdoc.xml","form_type":"4"}},{"id":2788088,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-03-16T20:19:40.000Z","date":"2021-03-12","kind":"exercise","acquired":true,"shares":25000,"price":0.605,"value":15125.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":635500,"source":{"system":"sec-edgar","filing":"0001437749-21-006164","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774921006164/rdgdoc.xml","form_type":"4"}},{"id":2962118,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-02T21:15:32.000Z","date":"2020-11-30","kind":"purchase","acquired":true,"shares":68000,"price":0.3755,"value":25534.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":610500,"source":{"system":"sec-edgar","filing":"0001437749-20-024716","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920024716/rdgdoc.xml","form_type":"4"}},{"id":2999021,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Warrant (right to buy)","published_at":"2020-10-28T20:35:08.000Z","date":"2020-10-22","kind":"purchase","acquired":true,"shares":24038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."}],"balance_after":611538,"derivative":{"exercise_price":0.57,"exercise_date":"2020-10-22","expiration_date":"2025-10-22","underlying":"Common Stock","underlying_shares":24038},"source":{"system":"sec-edgar","filing":"0001437749-20-021846","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920021846/rdgdoc.xml","form_type":"4"}},{"id":2999020,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-10-28T20:35:08.000Z","date":"2020-10-22","kind":"purchase","acquired":true,"shares":48076,"price":0.52,"value":24999.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Purchased pursuant to public offering that closed on October 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchased pursuant to public offering that closed on October 22, 2020."}],"balance_after":48076,"source":{"system":"sec-edgar","filing":"0001437749-20-021846","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920021846/rdgdoc.xml","form_type":"4"}},{"id":3100368,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2020-06-25T20:36:03.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/23/2020, and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested."}],"balance_after":587500,"derivative":{"exercise_price":0.61,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001437749-20-013868","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920013868/rdgdoc.xml","form_type":"4"}},{"id":3290132,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2020-02-05T21:47:09.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, and the remaining 75% will vest over the next three (3) years, commencing on 6/18/2020, until fully vested. The shares exercised on 2/3/2020 represent the shares that vested on 6/18/2019."},{"field":"shares","element":"transactionShares","label":"F4","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, and the remaining 75% will vest over the next three (3) years, commencing on 6/18/2020, until fully vested. The shares exercised on 2/3/2020 represent the shares that vested on 6/18/2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, and the remaining 75% will vest over the next three (3) years, commencing on 6/18/2020, until fully vested. The shares exercised on 2/3/2020 represent the shares that vested on 6/18/2019."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"250,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, and the remaining 75% will vest over the next three (3) years, commencing on 6/18/2020, until fully vested. The shares exercised on 2/3/2020 represent the shares that vested on 6/18/2019."}],"balance_after":187500,"derivative":{"exercise_price":0.43,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001437749-20-001806","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920001806/rdgdoc.xml","form_type":"4"}},{"id":3290131,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2020-02-05T21:47:09.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, and the remaining 50% will vest over the next two (2) years, commencing on 6/13/2020, until fully vested. The shares exercised on 2/3/2020 represent the shares that vested on 12/13/2018 and 6/13/2019."},{"field":"shares","element":"transactionShares","label":"F3","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, and the remaining 50% will vest over the next two (2) years, commencing on 6/13/2020, until fully vested. The shares exercised on 2/3/2020 represent the shares that vested on 12/13/2018 and 6/13/2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, and the remaining 50% will vest over the next two (2) years, commencing on 6/13/2020, until fully vested. The shares exercised on 2/3/2020 represent the shares that vested on 12/13/2018 and 6/13/2019."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"250,000 stock options were granted on 6/13/2018. 25% vested on 12/13/2018, 25% vested on 6/13/2019, and the remaining 50% will vest over the next two (2) years, commencing on 6/13/2020, until fully vested. The shares exercised on 2/3/2020 represent the shares that vested on 12/13/2018 and 6/13/2019."}],"balance_after":125000,"derivative":{"exercise_price":0.46,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-20-001806","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920001806/rdgdoc.xml","form_type":"4"}},{"id":3290130,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2020-02-05T21:47:09.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"100,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, 25% vested on 6/27/2018, 25% vested on 6/27/2019 and the remaining 25% will vest on 6/27/2020. The shares exercised on 2/3/2020 represent the shares that vested on 6/27/2017, 6/27/2018 and 6/27/2019."},{"field":"shares","element":"transactionShares","label":"F2","text":"100,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, 25% vested on 6/27/2018, 25% vested on 6/27/2019 and the remaining 25% will vest on 6/27/2020. The shares exercised on 2/3/2020 represent the shares that vested on 6/27/2017, 6/27/2018 and 6/27/2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, 25% vested on 6/27/2018, 25% vested on 6/27/2019 and the remaining 25% will vest on 6/27/2020. The shares exercised on 2/3/2020 represent the shares that vested on 6/27/2017, 6/27/2018 and 6/27/2019."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"100,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, 25% vested on 6/27/2018, 25% vested on 6/27/2019 and the remaining 25% will vest on 6/27/2020. The shares exercised on 2/3/2020 represent the shares that vested on 6/27/2017, 6/27/2018 and 6/27/2019."}],"balance_after":25000,"derivative":{"exercise_price":0.605,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-20-001806","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920001806/rdgdoc.xml","form_type":"4"}},{"id":3290129,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-05T21:47:09.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":62500,"price":0.43,"value":26875.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":542500,"source":{"system":"sec-edgar","filing":"0001437749-20-001806","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920001806/rdgdoc.xml","form_type":"4"}},{"id":3290128,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-05T21:47:09.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":125000,"price":0.46,"value":57500.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"balance_after":480000,"source":{"system":"sec-edgar","filing":"0001437749-20-001806","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920001806/rdgdoc.xml","form_type":"4"}},{"id":3290127,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-05T21:47:09.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":75000,"price":0.605,"value":45375.0,"ownership":{"direct":false,"nature":"By Woods Family Living Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On January 27, 2020, 280,000 shares were transferred to the Woods Family Living Trust. These shares were previously reported on Form 4 filed November 19, 2019."}],"balance_after":355000,"source":{"system":"sec-edgar","filing":"0001437749-20-001806","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920001806/rdgdoc.xml","form_type":"4"}},{"id":3367386,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-11-19T22:04:38.000Z","date":"2019-11-15","kind":"purchase","acquired":true,"shares":25000,"price":0.3898,"value":9745.0,"ownership":{"direct":true},"balance_after":280000,"source":{"system":"sec-edgar","filing":"0001437749-19-023222","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774919023222/rdgdoc.xml","form_type":"4"}},{"id":3367385,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-11-19T22:04:38.000Z","date":"2019-11-14","kind":"purchase","acquired":true,"shares":125000,"price":0.3964,"value":49550.0,"ownership":{"direct":true},"balance_after":255000,"source":{"system":"sec-edgar","filing":"0001437749-19-023222","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774919023222/rdgdoc.xml","form_type":"4"}},{"id":3480715,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Options (right to buy)","published_at":"2019-06-24T20:55:11.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/18/2019, and the remaining 75% will vest over the next three (3) years, commencing on 6/18/2020, until fully vested."}],"balance_after":600000,"derivative":{"exercise_price":0.43,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001437749-19-012552","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774919012552/rdgdoc.xml","form_type":"4"}},{"id":3764018,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2018-11-15T22:46:04.000Z","date":"2018-11-15","kind":"purchase","acquired":true,"shares":635,"price":0.3966,"value":251.841,"ownership":{"direct":true},"balance_after":130000,"source":{"system":"sec-edgar","filing":"0001437749-18-020966","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774918020966/rdgdoc.xml","form_type":"4"}},{"id":3764017,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2018-11-15T22:46:04.000Z","date":"2018-11-15","kind":"purchase","acquired":true,"shares":4365,"price":0.399,"value":1741.635,"ownership":{"direct":true},"balance_after":129365,"source":{"system":"sec-edgar","filing":"0001437749-18-020966","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774918020966/rdgdoc.xml","form_type":"4"}},{"id":3764016,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2018-11-15T22:46:04.000Z","date":"2018-11-14","kind":"purchase","acquired":true,"shares":125000,"price":0.3979,"value":49737.5,"ownership":{"direct":true},"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001437749-18-020966","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774918020966/rdgdoc.xml","form_type":"4"}},{"id":3889973,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63028,"kind":"person","name":"Woods Lori A","position":1,"cik":"0001393007","reported_name":"Woods Lori A","relationship":{"director":true,"officer":true,"officer_title":"Interim CEO"}}],"security":"Stock Options (right to buy)","published_at":"2018-06-20T00:27:46.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vests as of 12/13/2018, and the remaining 75% will vest over the next three (3) years, commencing on 6/13/2019, until fully vested."}],"balance_after":350000,"derivative":{"exercise_price":0.46,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001437749-18-012097","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774918012097/rdgdoc.xml","form_type":"4"}}]}